ITMCTR2000003129
Not yet recruiting
Phase 1
Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)
Conditionsovel Coronavirus Pneumonia (COVID-19)
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Patients with Novel coronavirus pneumonia diagnosed according to ;
- •(2\) Inpatients aged \>18 years old;
- •(3\) Patients Know the informed consent, voluntary participate in this clinical trial and sign informed consent.
Exclusion Criteria
- •(1\) Death is expected within 48 hours;
- •(2\) Basic diseases such as primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory malformation , congenital heart disease, gastroesophageal reflux disease, congenital pulmonary airway malformation and more with the exact evidence of bacterial infection;
- •(3\) Patients with the following conditions: Daily treatment of asthma, chronic respiratory disease, bacterial infections of the respiratory system such as suppurative tonsillitis, acute tracheal bronchitis, sinusitis, otitis media, etc that affect clinical trial evaluation. Chest CT confirmed the existence of severe pulmonary interstitial lesions, bronchiectasis and other basic pulmonary diseases;
- •(4\) As judged by the researcher, past or present diseases may affect the participation of patients in the research outcome, including malignant diseases, autoimmune diseases, severe malnutrition, liver and kidney diseases, hematological diseases, nervous system diseases, endocrine diseases and serious diseases affecting the immune system such as human immunodeficiency virus (HIV) infection, or blood system, or splenectomy, organ transplantation, etc.
- •(5\) Mental state unable to cooperation: suffering from mental illness, unabling to control or express clearly;
- •(6\) Allergic constitution (such as allergic to two or more drugs or food) or history of alleric to this product and conventional treatment drugs;
- •(7\) History of substance abuse or dependence;
- •(8\) Pregnant or nursing women;
- •(9\) Participants in clinical trials of other drugs in the past 3 months;
- •(10\) Researchers believe that patients are not suitable for any other situation in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Study on the therapeutic effect and mechanism of all regulation of acupuncture and moxibustionon postmenopausal osteoporosisPostmenopausal osteoporosisITMCTR2200005922Affiliated Hospital of Yunnan University
Not yet recruiting
Phase 1
Tai Chi Postural Training for dyskinesia rehabilitation: study protocol for a randomised controlled trial in convalescent ischemic stroke patientsITMCTR2000003309Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine
Recruiting
Phase 2
Effects of Neural Mobilization on Nerve Conduction Velocity and Neuropathic Symptoms in patients with Diabetic Peripheral NeuropathyDiabetes Peripheral NeuropathyTCTR20171215002ational Chen Kung University120
Completed
Phase 2
Evaluation of the therapeutic effects of Iranian Traditional Medicine (Hab Shabyar) in patients with open-angle glaucoma: A double-blind clinical trialopen-angle glaucoma.Primary open-angle glaucomaIRCT2016052828127N1Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences50
Not yet recruiting
Not Applicable
Clinical Investigation of the Therapeutic Effect of Posterior Lumbar Interbody Fusion using Autologous Adipose tissue derived Stromal Vascular FractioKCT0009328Bundang CHA General Hospital10